Elianne Roelandse-Koop

DR.

Affiliatie VU Other Academic Staff, Central Diagnostic Laboratory

Specialization

Focus of research

Latest publications

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer
de Boo, L. W., Jóźwiak, K., ter Hoeve, N. D., van Diest, P. J., Opdam, M., Wang, Y., Schmidt, M. K., de Jong, V., Kleiterp, S., Cornelissen, S., Baars, D., Koornstra, R. H. T., Kerver, E. D., van Dalen, T., Bins, A. D., Beeker, A., van den Heiligenberg, S. M., de Jong, P. C., Bakker, S. D., Rietbroek, R. C., & 30 othersKonings, I. R., Blankenburgh, R., Bijlsma, R. M., Imholz, A. L. T., Stathonikos, N., Vreuls, W., Sanders, J., Rosenberg, E. H., Koop, E. A., Varga, Z., van Deurzen, C. H. M., Mooyaart, A. L., Córdoba, A., Groen, E., Bart, J., Willems, S. M., Zolota, V., Wesseling, J., Sapino, A., Chmielik, E., Ryska, A., Broeks, A., Voogd, A. C., van der Wall, E., Siesling, S., Salgado, R., Dackus, G. M. H. E., Hauptmann, M., Kok, M. & Linn, S. C., 1 Mar 2024, In: ESMO open. 9, 3, 102923.
Research output: Contribution to journal › Article › Academic › peer-review
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
COBRA KAI Study Team, 1 Jul 2023, In: EClinicalMedicine. 61, 102040.
Research output: Contribution to journal › Article › Academic › peer-review
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
Haggenburg, S., Lissenberg-Witte, B. I., van Binnendijk, R. S., den Hartog, G., Bhoekhan, M. S., Haverkate, N. J. E., de Rooij, D. M., van Meerloo, J., Cloos, J., Kootstra, N. A., Wouters, D., Weijers, S. S., van Leeuwen, E. M. M., Bontkes, H. J., Tonouh-Aajoud, S., Heemskerk, M. H. M., Sanders, R. W., Roelandse-Koop, E., Hofsink, Q., Groen, K., & 28 othersÇetinel, L., Schellekens, L., den Hartog, Y. M., Toussaint, B., Kant, I. M. J., Graas, T., de Pater, E., Dik, W. A., Engel, M. D., Pierie, C. R. N., Janssen, S. R., van Dijkman, E., Poniman, M., Burger, J. A., Bouhuijs, J. H., Smits, G., Rots, N. Y., Zweegman, S., Kater, A. P., van Meerten, T., Mutsaers, P. G. N. J., van Doesum, J. A., Broers, A. E. C., van Gils, M. J., Goorhuis, A., Rutten, C. E., Hazenberg, M. D. & Nijhof, I. S., 8 Mar 2022, In: Blood advances. 6, 5, p. 1537-1546 10 p.
Research output: Contribution to journal › Article › Academic › peer-review
All publications

Elianne Roelandse-Koop

Specialization

Focus of research

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer

Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

We use cookies